Michele Ollier

CIK 1503685 · last filed 2016-12-14

Michele Ollier is a corporate insider who has filed 8 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing shows the insider exercised options on $1.2M of NERV on Dec 14, 2016. Across all open-market trades the lifetime net is −$9.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.37M

Companies

2

Total Filings

8

Lifetime Open-Market Net

-$9.66M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
NERV	Director	586,363	$4.04	$2.37M	$699.7K	4	2016-12-14
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	Director	2,131,827	—	—	-$10.36M	4	2011-08-02

Recent Filings

8 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2016-12-14	NERV	Exer (X)	+202,634	$1.17M	EDGAR
2016-08-12	NERV	Sell (S)	−1,000,000	-$10.00M	EDGAR
2015-03-20	NERV	Buy (P)	+202,634	$974.7K	EDGAR
2014-07-09	NERV	Mixed	+1,796,832	$10.78M	EDGAR
2011-08-02	Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	Sell (S)	−36,788	-$537.4K	EDGAR
2011-07-01	Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	Sell (S)	−877,723	-$12.82M	EDGAR
2011-06-03	Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	Grant (A)	—	$0	EDGAR
2010-10-27	Aegerion Pharmaceuticals, Inc. (AEGR) Delisted	Mixed	+3,041,986	$9.70M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.